MindImmune Therapeutics Company
![](/storage/logos_100px/MindImmune Therapeutics.jpg)
MindImmune Therapeutics is a pharmaceutical company that develops drugs which treat diseases of the central nervous system.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Kingston, Rhode Island, United States
Founded Date:
2016
Employees Number:
1-10
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Register and Claim Ownership